Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Drops By 62.1%

Coloplast A/S (OTCMKTS:CLPBY) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 106,400 shares, a drop of 62.1% from the March 15th total of 280,600 shares. Based on an average daily trading volume, of 354,300 shares, the short-interest ratio is currently 0.3 days.

Coloplast A/S Stock Performance

CLPBY traded up $0.05 during midday trading on Wednesday, hitting $10.62. The company had a trading volume of 248,320 shares, compared to its average volume of 210,093. The stock’s 50 day moving average price is $10.67 and its 200 day moving average price is $11.58. Coloplast A/S has a 52 week low of $9.67 and a 52 week high of $14.14. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. As a group, analysts predict that Coloplast A/S will post 0.31 EPS for the current year.

Analyst Upgrades and Downgrades

CLPBY has been the topic of a number of research analyst reports. Royal Bank of Canada raised shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd. Sanford C. Bernstein upgraded Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.